Log in to save to my catalogue

Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review

Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11704153

Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review

About this item

Full title

Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review

Publisher

Netherlands: Elsevier B.V

Journal title

Critical care and resuscitation, 2024-12, Vol.26 (4), p.286-294

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier B.V

More information

Scope and Contents

Contents

To assess current evidence regarding guanfacine use in hospitalized patients with delirium.
Delirium is a common and important complication of critical illness. Central alpha-2 agonists are often used for symptomatic management. Guanfacine is an enteral central alpha-2 agonist approved for the treatment of attention deficit hyperactivity disorde...

Alternative Titles

Full title

Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11704153

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11704153

Other Identifiers

ISSN

1441-2772

E-ISSN

2652-9335

DOI

10.1016/j.ccrj.2024.08.009

How to access this item